| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |